Max Biopharma

Biopharmaceutical company pioneering Oxysterol Therapeutics® for debilitating and fatal human diseases

placeLos Angeles, California, United States calendar_todayFounded 2010 groups5 employees language maxbiopharma.com

Innovation

5 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 281 times.

YearFilings
20172
20182
20191
20202
20211
20222
20233
20241

Social engagement

Social engagement: 747 social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%

Recent activity

10 Apr 2026
Leadership hire
Scientific Advisory Board member
12 Nov 2025
Product launch
Oxy210
Coming soon